Stepan Reports Second Quarter 2024 Results
Second Quarter 2024 Highlights
- Reported net income was
$9.5 million , down 25% versus prior year. Adjusted net income(1) was$9.4 million , down 22% versus prior year, largely due to a higher effective tax rate in 2024. - Pre-tax earnings were negatively impacted by
$18.9 million due to higher operating costs at our Millsdale site, primarily related to a flood event ($11.8 million ), pre-commissioning expenses at our new Alkoxylation investment inPasadena, Texas ($3.6 million ) and expenses related to a criminal fraud event at a subsidiary inAsia ($3.5 million ). - EBITDA(2) was
$47.9 million and Adjusted EBITDA(2) was$47.7 million , up 3% and 4% respectively, year-over-year. - Global sales volume was up 4% year-over-year. Surfactant and Polymer sales volume was up 5% and 2%, respectively.
- Cash from Operations was
$29.5 million during the quarter. Free cash flow(3) for the quarter was slightly negative due to the higher expenses noted above. - The Company is on track to deliver its
$50 million cost out goal for 2024 and recognized$2.7 million in pre-tax savings, net of the higher operating costs at Millsdale, in the second quarter.
First Half 2024 Highlights
- Reported net income was
$23.4 million , down 19% versus prior year. Adjusted net income(1) was$24.1 million , down 16% year-over-year, largely due to a higher effective tax rate in 2024. - EBITDA(2) was
$98.0 million and Adjusted EBITDA(2) was$98.9 million , up 3% and 5% respectively, year-over-year. - Global sales volume was up 2% year-over-year. Global sales volume, excluding declines in our Agricultural and commodity Phthalic Anhydride businesses, was up 5%.
"Second quarter earnings were significantly impacted by higher operational expenses at our Millsdale site, start up costs related to our new
Financial Summary |
||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
($ in thousands, except per share data) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
|
$ |
556,405 |
$ |
579,975 |
(4) |
% |
$ |
1,107,823 |
$ |
1,231,411 |
(10) |
% |
||||||||||||
Operating Income |
$ |
18,667 |
$ |
17,809 |
5 |
% |
$ |
38,836 |
$ |
38,866 |
(0) |
% |
||||||||||||
Net Income |
$ |
9,521 |
$ |
12,684 |
(25) |
% |
$ |
23,414 |
$ |
28,826 |
(19) |
% |
||||||||||||
Earnings per Diluted Share |
$ |
0.42 |
$ |
0.55 |
(24) |
% |
$ |
1.02 |
$ |
1.25 |
(18) |
% |
||||||||||||
Adjusted Net Income * |
$ |
9,396 |
$ |
12,057 |
(22) |
% |
$ |
24,052 |
$ |
28,476 |
(16) |
% |
||||||||||||
Adjusted Earnings per |
$ |
0.41 |
$ |
0.53 |
(23) |
% |
$ |
1.05 |
$ |
1.24 |
(15) |
% |
* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share. |
Percentage Change in
Net sales in the second quarter of 2024 decreased 4% year-over-year primarily due to lower selling prices that were mainly attributable to the pass-through of lower raw material costs and less favorable product mix. These lower selling prices were partially offset by a 4% increase in global sales volume.
Three Months Ended |
Six Months Ended |
|||||||
Volume |
4 |
% |
2 |
% |
||||
Selling Price & Mix |
(8) |
% |
(13) |
% |
||||
Foreign Translation |
(—) |
% |
1 |
% |
||||
Total |
(4) |
% |
(10) |
% |
Segment Results |
||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
|
||||||||||||||||||||||||
Surfactants |
$ |
379,795 |
$ |
391,686 |
(3) |
% |
$ |
770,615 |
$ |
859,514 |
(10) |
% |
||||||||||||
Polymers |
$ |
159,757 |
$ |
164,515 |
(3) |
% |
$ |
305,265 |
$ |
325,642 |
(6) |
% |
||||||||||||
Specialty Products |
$ |
16,853 |
$ |
23,774 |
(29) |
% |
$ |
31,943 |
$ |
46,255 |
(31) |
% |
||||||||||||
Total |
$ |
556,405 |
$ |
579,975 |
(4) |
% |
$ |
1,107,823 |
$ |
1,231,411 |
(10) |
% |
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
($ in thousands, all amounts pre-tax) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
Operating Income |
||||||||||||||||||||||||
Surfactants |
$ |
17,062 |
$ |
15,140 |
13 |
% |
$ |
43,142 |
$ |
42,196 |
2 |
% |
||||||||||||
Polymers |
$ |
13,597 |
$ |
16,321 |
(17) |
% |
$ |
21,979 |
$ |
26,325 |
(17) |
% |
||||||||||||
Specialty Products |
$ |
7,319 |
$ |
3,773 |
94 |
% |
$ |
11,587 |
$ |
6,302 |
84 |
% |
||||||||||||
Total Segment |
$ |
37,978 |
$ |
35,234 |
8 |
% |
$ |
76,708 |
$ |
74,823 |
3 |
% |
||||||||||||
Corporate Expenses |
$ |
(19,311) |
$ |
(17,425) |
11 |
% |
$ |
(37,872) |
$ |
(35,957) |
5 |
% |
||||||||||||
Consolidated |
$ |
18,667 |
$ |
17,809 |
5 |
% |
$ |
38,836 |
$ |
38,866 |
(0) |
% |
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
($ in millions) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
EBITDA |
||||||||||||||||||||||||
Surfactants |
$ |
35.0 |
$ |
31.1 |
13 |
% |
$ |
78.6 |
$ |
73.5 |
7 |
% |
||||||||||||
Polymers |
$ |
21.8 |
$ |
24.6 |
(11) |
% |
$ |
38.2 |
$ |
42.9 |
(11) |
% |
||||||||||||
Specialty Products |
$ |
8.8 |
$ |
5.2 |
69 |
% |
$ |
14.6 |
$ |
9.1 |
60 |
% |
||||||||||||
Unallocated Corporate |
$ |
(17.7) |
$ |
(14.2) |
25 |
% |
$ |
(33.4) |
$ |
(30.6) |
9 |
% |
||||||||||||
Consolidated EBITDA |
$ |
47.9 |
$ |
46.7 |
3 |
% |
$ |
98.0 |
$ |
94.9 |
3 |
% |
||||||||||||
Adjusted EBITDA |
||||||||||||||||||||||||
Surfactants |
$ |
35.0 |
$ |
31.0 |
13 |
% |
$ |
78.6 |
$ |
73.4 |
7 |
% |
||||||||||||
Polymers |
$ |
21.8 |
$ |
24.6 |
(11) |
% |
$ |
38.2 |
$ |
42.9 |
(11) |
% |
||||||||||||
Specialty Products |
$ |
8.8 |
$ |
5.2 |
69 |
% |
$ |
14.6 |
$ |
9.1 |
60 |
% |
||||||||||||
Unallocated Corporate |
$ |
(17.9) |
$ |
(15.0) |
19 |
% |
$ |
(32.5) |
$ |
(30.9) |
5 |
% |
||||||||||||
Consolidated Adjusted EBITDA |
$ |
47.7 |
$ |
45.8 |
4 |
% |
$ |
98.9 |
$ |
94.5 |
5 |
% |
Consolidated adjusted EBITDA increased
- Surfactant net sales were
$379.8 million for the quarter, a 3% decrease versus the prior year. Selling prices were down 8% primarily due to the pass-through of lower raw material costs, less favorable product mix and competitive pricing pressures inLatin America . Sales volume was up 5% year-over-year as double digit growth within the Laundry and Cleaning, Construction and Industrial Solutions and Oilfield end markets and with our distribution partners was offset by lower Agricultural demand due to continued customer and channel inventory destocking. Foreign currency translation had a negligible impact on net sales. Surfactant adjusted EBITDA(2) for the quarter increased$4.0 million , or 13%, versus the prior year. This increase was primarily driven by the 5% growth in sales volume and slight margin improvement that was partially offset by pre-operating expenses at the Company's new alkoxylation facility being built inPasadena, Texas and higher expenses associated with operational and infrastructure issues at the Millsdale plant. - Polymer net sales were
$159.8 million for the quarter, a 3% decrease versus the prior year. Selling prices decreased 6%, primarily due to the pass-through of lower raw material costs. Sales volume increased 2% in the quarter as a 2% increase in global Rigid Polyols demand and a 28% increase within the Specialty Polyols business was partially offset by lower commodity Phthalic Anhydride volume. Foreign currency translation positively impacted net sales by 1%. Polymer adjusted EBITDA(2) decreased$2.8 million , or 11%, versus the prior year driven by a non-cash Phthalic Anhydride-related catalyst write-off at the Millsdale site and higher costs incurred at Millsdale due to operational and infrastructure issues. - Specialty Product net sales were
$16.9 million for the quarter, a 29% decrease versus the prior year, primarily due to lower prices. Sales volume was down 2% versus the prior year while adjusted EBITDA(2) increased$3.6 million , or 69%. The increase in adjusted EBITDA(2) was primarily due to higher unit margins within the medium chain triglycerides product line.
Asia Event
On
Outlook
"We expect second half EBITDA to improve versus the prior year based on continued volume growth and a significant reduction in second half operational expenses at our Millsdale site, which was the majority of the significant variance in second quarter expenses. The on-going recovery in Rigid Polyols and the expected second half of the year recovery of the Agricultural Chemicals business should drive improved earnings," said
Notes |
|
(1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share. |
|
(2) EBITDA and adjusted EBITDA are non-GAAP measures. See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA. |
|
(3) Free Cash Flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures. |
|
Conference Call
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Headquartered in
The Company's common stock is traded on the
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about
There are a number of risks, uncertainties and other important factors, many of which are beyond
These forward-looking statements are made only as of the date hereof, and
* * * * *
Tables follow
Table I |
||||||||||||||||
STEPAN COMPANY |
||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
|
$ |
556,405 |
$ |
579,975 |
$ |
1,107,823 |
$ |
1,231,411 |
||||||||
Cost of Sales |
486,853 |
513,578 |
967,990 |
1,091,454 |
||||||||||||
Gross Profit |
69,552 |
66,397 |
139,833 |
139,957 |
||||||||||||
Operating Expenses: |
||||||||||||||||
Selling |
11,828 |
11,109 |
23,216 |
24,176 |
||||||||||||
Administrative |
24,569 |
22,589 |
47,259 |
45,228 |
||||||||||||
Research, Development and Technical Services |
14,093 |
14,105 |
28,349 |
29,243 |
||||||||||||
Deferred Compensation Expense |
395 |
743 |
2,173 |
2,245 |
||||||||||||
50,885 |
48,546 |
100,997 |
100,892 |
|||||||||||||
Business Restructuring Expense |
- |
42 |
- |
199 |
||||||||||||
Operating Income |
18,667 |
17,809 |
38,836 |
38,866 |
||||||||||||
Other Income (Expense): |
||||||||||||||||
Interest, Net |
(2,661) |
(3,865) |
(5,732) |
(6,687) |
||||||||||||
Other, Net |
1,200 |
2,370 |
3,562 |
4,038 |
||||||||||||
(1,461) |
(1,495) |
(2,170) |
(2,649) |
|||||||||||||
Income Before Provision for Income Taxes |
17,206 |
16,314 |
36,666 |
36,217 |
||||||||||||
Provision for Income Taxes |
7,685 |
3,630 |
13,252 |
7,391 |
||||||||||||
Net Income |
9,521 |
12,684 |
23,414 |
28,826 |
||||||||||||
Net Income Per Common Share |
||||||||||||||||
Basic |
$ |
0.42 |
$ |
0.56 |
$ |
1.03 |
$ |
1.27 |
||||||||
Diluted |
$ |
0.42 |
$ |
0.55 |
$ |
1.02 |
$ |
1.25 |
||||||||
Shares Used to Compute Net Income Per |
||||||||||||||||
Basic |
22,827 |
22,768 |
22,825 |
22,763 |
||||||||||||
Diluted |
22,936 |
22,945 |
22,942 |
22,970 |
Table II |
||||||||||||||||||||||||||||||||
Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share* |
||||||||||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2024 |
EPS |
2023 |
EPS |
2024 |
EPS |
2023 |
EPS |
||||||||||||||||||||||||
Net Income Reported |
$ |
9,521 |
$ |
0.42 |
$ |
12,684 |
$ |
0.55 |
$ |
23,414 |
$ |
1.02 |
$ |
28,826 |
$ |
1.25 |
||||||||||||||||
Deferred Compensation |
$ |
(305) |
$ |
(0.01) |
$ |
(653) |
$ |
(0.02) |
$ |
(693) |
$ |
(0.03) |
$ |
(757) |
$ |
(0.03) |
||||||||||||||||
Business Restructuring Expense |
$ |
- |
$ |
- |
$ |
31 |
$ |
- |
$ |
- |
$ |
- |
$ |
146 |
$ |
0.01 |
||||||||||||||||
Cash-Settled SARs Income |
$ |
- |
$ |
- |
$ |
(44) |
$ |
- |
$ |
- |
$ |
- |
$ |
(84) |
$ |
- |
||||||||||||||||
Environmental Remediation |
$ |
180 |
$ |
- |
$ |
39 |
$ |
- |
$ |
1,331 |
$ |
0.06 |
$ |
345 |
$ |
0.01 |
||||||||||||||||
Adjusted Net Income |
$ |
9,396 |
$ |
0.41 |
$ |
12,057 |
$ |
0.53 |
$ |
24,052 |
$ |
1.05 |
$ |
28,476 |
$ |
1.24 |
* |
All amounts in this table are presented after-tax |
The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition. The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators. Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years. These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies. The Company's Annual Report on Form 10-K for the year ended
Summary of Second Quarter 2024 Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.
- Deferred Compensation: The second quarter of 2024 reported net income includes
$0.3 million of after-tax income versus$0.7 million of after-tax income in the prior year. - Environmental Remediation – The second quarter of 2024 reported net income includes
$0.2 million of after-tax expense versus less than$0.1 million of after-tax expense in the prior year.
Table III |
||||||||||||||||||||||||||||||||
Reconciliation of Pre-Tax to After-Tax Adjustments |
||||||||||||||||||||||||||||||||
Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the transactions occurred. |
||||||||||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2024 |
EPS |
2023 |
EPS |
2024 |
EPS |
2023 |
EPS |
||||||||||||||||||||||||
Pre-Tax Adjustments |
||||||||||||||||||||||||||||||||
Deferred Compensation |
$ |
(407) |
$ |
(871) |
$ |
(924) |
$ |
(1,009) |
||||||||||||||||||||||||
Business Restructuring Expense |
$ |
- |
$ |
42 |
$ |
- |
$ |
199 |
||||||||||||||||||||||||
Cash-Settled SARs Income |
$ |
- |
$ |
(58) |
$ |
- |
$ |
(111) |
||||||||||||||||||||||||
Environmental Remediation |
$ |
240 |
$ |
52 |
$ |
1,774 |
$ |
461 |
||||||||||||||||||||||||
Total Pre-Tax Adjustments |
$ |
(167) |
$ |
(835) |
$ |
850 |
$ |
(460) |
||||||||||||||||||||||||
Cumulative Tax Effect |
$ |
42 |
$ |
208 |
$ |
(212) |
$ |
110 |
||||||||||||||||||||||||
After-Tax Adjustments |
$ |
(125) |
$ |
- |
$ |
(627) |
$ |
(0.02) |
$ |
638 |
$ |
0.03 |
$ |
(350) |
$ |
(0.01) |
||||||||||||||||
Table IV |
||||||||||||||||||||||||
Deferred Compensation Plans |
||||||||||||||||||||||||
The full effect of the deferred compensation plans on quarterly pre-tax income was |
||||||||||||||||||||||||
2024 |
2023 |
|||||||||||||||||||||||
6/30 |
3/31 |
12/31 |
9/30 |
6/30 |
3/31 |
|||||||||||||||||||
|
$ |
83.96 |
$ |
90.04 |
$ |
94.55 |
$ |
74.97 |
$ |
95.56 |
$ |
103.03 |
||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
($ in thousands) |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Deferred Compensation |
||||||||||||||||
Operating Expense |
$ |
(395) |
$ |
(743) |
$ |
(2,173) |
$ |
(2,245) |
||||||||
Other, net – Mutual Fund Gain |
802 |
1,614 |
3,097 |
3,254 |
||||||||||||
Total Pre-Tax |
$ |
407 |
$ |
871 |
$ |
924 |
$ |
1,009 |
||||||||
Total After-Tax |
$ |
305 |
$ |
653 |
$ |
693 |
$ |
757 |
Effects of Foreign Currency Translation |
||||||||||||||||||||||||||||||||
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. The table below presents the impact that foreign currency translation had on select income statement line items. |
||||||||||||||||||||||||||||||||
($ in millions) |
Three Months Ended |
Change |
Change |
Six Months Ended |
Change |
Change |
||||||||||||||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||||||||||||||||||
|
$ |
556.4 |
$ |
580.0 |
$ |
(23.6) |
$ |
0.8 |
$ |
1,107.8 |
$ |
1,231.4 |
$ |
(123.6) |
$ |
12.6 |
||||||||||||||||
Gross Profit |
69.6 |
66.4 |
$ |
3.2 |
(0.2) |
139.8 |
140.0 |
$ |
(0.2) |
1.1 |
||||||||||||||||||||||
Operating Income |
18.7 |
17.8 |
$ |
0.9 |
- |
38.8 |
38.9 |
$ |
(0.1) |
0.6 |
||||||||||||||||||||||
Pretax Income |
17.2 |
16.3 |
$ |
0.9 |
(0.1) |
36.7 |
36.2 |
$ |
0.5 |
0.5 |
Corporate Expenses |
||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
Total Corporate Expenses |
$ |
19,311 |
$ |
17,424 |
11 |
% |
$ |
37,872 |
$ |
35,957 |
5 |
% |
||||||||||||
Less: |
||||||||||||||||||||||||
Deferred Compensation Expense |
$ |
395 |
$ |
743 |
(47) |
% |
$ |
2,173 |
$ |
2,245 |
(3) |
% |
||||||||||||
Business Restructuring Expense |
$ |
- |
$ |
42 |
(100) |
% |
$ |
- |
$ |
199 |
(100) |
% |
||||||||||||
Environmental Remediation |
$ |
240 |
$ |
52 |
362 |
% |
$ |
1,774 |
$ |
461 |
285 |
% |
||||||||||||
Adjusted Corporate Expenses |
$ |
18,676 |
$ |
16,587 |
13 |
% |
$ |
33,925 |
$ |
33,052 |
3 |
% |
Adjusted Corporate expenses increased
Table V |
||||||||
Stepan Company |
||||||||
|
|
|||||||
ASSETS |
||||||||
Current Assets |
$ |
867,140 |
$ |
851,883 |
||||
Property, Plant & Equipment, Net |
1,195,117 |
1,206,665 |
||||||
Other Assets |
286,333 |
304,806 |
||||||
Total Assets |
$ |
2,348,590 |
$ |
2,363,354 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||
Current Liabilities |
$ |
655,195 |
$ |
607,870 |
||||
Deferred Income Taxes |
10,224 |
10,373 |
||||||
Long-term Debt |
374,708 |
401,248 |
||||||
Other Non-current Liabilities |
116,027 |
127,373 |
||||||
Total Stepan Company Stockholders' Equity |
1,192,436 |
1,216,490 |
||||||
Total Liabilities and Stockholders' Equity |
$ |
2,348,590 |
$ |
2,363,354 |
Selected Balance Sheet Information |
||||||||||||
The Company's total debt increased by |
||||||||||||
($ in millions) |
|
|
|
|||||||||
Net Debt |
||||||||||||
Total Debt |
$ |
657.1 |
$ |
646.0 |
$ |
654.1 |
||||||
Cash |
124.7 |
125.8 |
129.8 |
|||||||||
Net Debt |
$ |
532.4 |
$ |
520.2 |
$ |
524.3 |
||||||
Equity |
1,192.4 |
1,214.5 |
1,216.5 |
|||||||||
Net Debt + Equity |
$ |
1,724.8 |
$ |
1,734.7 |
$ |
1,740.8 |
||||||
Net Debt / (Net Debt + Equity) |
31 |
% |
30 |
% |
30 |
% |
The major working capital components were: |
||||||||||||
($ in millions) |
|
|
|
|||||||||
Net Receivables |
$ |
437.3 |
$ |
446.6 |
$ |
422.1 |
||||||
Inventories |
266.0 |
257.1 |
265.6 |
|||||||||
Accounts Payable |
(251.2) |
(256.9) |
(233.0) |
|||||||||
$ |
452.1 |
$ |
446.8 |
$ |
454.7 |
Table VI |
||||||||||||||||||||
Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA to Operating Income |
||||||||||||||||||||
Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. |
||||||||||||||||||||
Three Months Ended |
||||||||||||||||||||
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
Operating Income |
$ |
17.1 |
$ |
13.6 |
$ |
7.3 |
$ |
(19.3) |
$ |
18.7 |
||||||||||
Depreciation and Amortization |
$ |
17.9 |
$ |
8.2 |
$ |
1.5 |
$ |
0.4 |
$ |
28.0 |
||||||||||
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
1.2 |
$ |
1.2 |
||||||||||
EBITDA |
$ |
35.0 |
$ |
21.8 |
$ |
8.8 |
$ |
(17.7) |
$ |
47.9 |
||||||||||
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.4) |
$ |
(0.4) |
||||||||||
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.2 |
$ |
0.2 |
||||||||||
Adjusted EBITDA |
$ |
35.0 |
$ |
21.8 |
$ |
8.8 |
$ |
(17.9) |
$ |
47.7 |
||||||||||
Three Months Ended |
||||||||||||||||||||
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
Operating Income |
$ |
15.1 |
$ |
16.3 |
$ |
3.8 |
$ |
(17.4) |
$ |
17.8 |
||||||||||
Depreciation and Amortization |
$ |
16.0 |
$ |
8.3 |
$ |
1.4 |
$ |
0.8 |
$ |
26.5 |
||||||||||
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
2.4 |
$ |
2.4 |
||||||||||
EBITDA |
$ |
31.1 |
$ |
24.6 |
$ |
5.2 |
$ |
(14.2) |
$ |
46.7 |
||||||||||
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.9) |
$ |
(0.9) |
||||||||||
Cash Settled SARs |
$ |
(0.1) |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.1) |
||||||||||
Business Restructuring |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
||||||||||
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.1 |
$ |
0.1 |
||||||||||
Adjusted EBITDA |
$ |
31.0 |
$ |
24.6 |
$ |
5.2 |
$ |
(15.0) |
$ |
45.8 |
||||||||||
Six Months Ended |
||||||||||||||||||||
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
Operating Income |
$ |
43.1 |
$ |
22.0 |
$ |
11.6 |
$ |
(37.9) |
$ |
38.8 |
||||||||||
Depreciation and Amortization |
$ |
35.5 |
$ |
16.2 |
$ |
3.0 |
$ |
0.9 |
$ |
55.6 |
||||||||||
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
3.6 |
$ |
3.6 |
||||||||||
EBITDA |
$ |
78.6 |
$ |
38.2 |
$ |
14.6 |
$ |
(33.4) |
$ |
98.0 |
||||||||||
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.9) |
$ |
(0.9) |
||||||||||
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
1.8 |
$ |
1.8 |
||||||||||
Adjusted EBITDA |
$ |
78.6 |
$ |
38.2 |
$ |
14.6 |
$ |
(32.5) |
$ |
98.9 |
||||||||||
Six Months Ended |
||||||||||||||||||||
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
Operating Income |
$ |
42.2 |
$ |
26.3 |
$ |
6.3 |
$ |
(35.9) |
$ |
38.9 |
||||||||||
Depreciation and Amortization |
$ |
31.3 |
$ |
16.6 |
$ |
2.8 |
$ |
1.3 |
$ |
52.0 |
||||||||||
Other, Net Income (Expense) |
$ |
- |
$ |
- |
$ |
- |
$ |
4.0 |
$ |
4.0 |
||||||||||
EBITDA |
$ |
73.5 |
$ |
42.9 |
$ |
9.1 |
$ |
(30.6) |
$ |
94.9 |
||||||||||
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(1.0) |
$ |
(1.0) |
||||||||||
Cash Settled SARs |
$ |
(0.1) |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.1) |
||||||||||
Business Restructuring |
$ |
- |
$ |
- |
$ |
- |
$ |
0.2 |
$ |
0.2 |
||||||||||
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.5 |
$ |
0.5 |
||||||||||
Adjusted EBITDA |
$ |
73.4 |
$ |
42.9 |
$ |
9.1 |
$ |
(30.9) |
$ |
94.5 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-second-quarter-2024-results-302210820.html
SOURCE
Luis E. Rojo 847-446-7500